 |
anti-TCR murine monoclonal antibody (MAb, type IgM) |
|---|---|
| Trade Name | |
| Orphan Indication | Patients 16 years of age and younger with immune-mediated T1DM and preserved pancreatic beta cell function |
| USA Market Approval | USA |
| USA Designation Date | 2010-06-07 00:00:00 |
| Sponsor | Tolera Therapeutics, Inc.;350 E. Michigan Avenue;Kalamazoo, Michigan, 49001 |
